Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

McBride grows first-half profits as volumes improve

(Sharecast News) - White-label and branded cleaning products group McBride managed to grow profits and revenues in its first half, and said it remains on track to hit full-year forecasts, helped by market conditions and operational delivery. Revenues in the six months to 31 December totalled £471.1m, up 0.7% on the previous year but 2.9% higher if currencies had remained stable.

Group volumes were up 5.9% year-on-year, with progress in McBride's core strategic focus areas of Germany and the laundry market. Meanwhile, contract manufacturing volumes were 69% higher, making up 13.4% of total revenue (up 1.9% on last year), with the company hoping to grow this proportion to 25% of total revenue.

"Despite the backdrop of inflation, strong operational delivery, careful management of costs and tight management of margins have contributed to a period of steady, sustainable growth," the company said.

Adjusted pre-tax profit were up 4.3% year-on-year at £26.7m, while net debt reduced to £117.6m from £145.7m a year earlier.

"With the group's prospects in a much healthier position and with a more normalised debt position, the board recently announced its intention to reinstate an annual dividend, details of which will be communicated at the time of the final results in September 2025," said chief executive Chris Smith.

McBride said full-year earnings are on track to be line with internal expectations.

"Materials costs are generally flat, with the rises in certain materials costs seen in the second quarter expected to moderate in the second half, but other inflation remains evident across our activities," the company said.

Shares were down 2.5% at 139p in early deals on Tuesday.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.